Speakers

Template for presenters

Background 1 for speakers, moderators and presenters

Background 2 for speakers, moderators and presenters

Background 3 for speakers, moderators and presenters

Sara Abdulla

Professor Mohammad Ali

Wole Ameyan

WHO

Wole Ameyan, MBBS, MIPH is an adolescent HIV specialist with wide ranging experience in program and policy areas. Trained as a medical doctor and with a master’s degree in international public health, Wole has extensive experience in working closely with governments and stakeholders towards driving the agenda for effective programming towards improving access to quality HIV care for adolescents. Having worked with government ministries, NGOs and the UN developing and supporting the delivery of evidence-based service delivery interventions through country owned and sustainable health systems, Wole’s work covers policy development as well as technical support including for capacity building and tools development to drive the adolescent health and HIV agenda. Wole currently works at the headquarters of the World Health Organization in Geneva as Technical Officer on adolescent HIV, a role that spans prevention and treatment scopes of work. He is particularly interested in and a strong advocate for the meaningful engagement of adolescents living with and at high risk of HIV in all facets of programs.

Hon. Dr. Frank Anthony

Ministry of Health

Dr. Frank Anthony has been practicing medicine in Guyana since1993. In addition to being in clinical practice over the years, Dr. Anthony taught at the University of Guyana as an adjunct professor in Public Health. He also served in various capacities, including as the Executive Director of the Health Sector Development Unit, Member of the Guyana Medical Council, Member of the Constitution Reform Commission, Member of the University of Guyana Council, Vice-Chair of the Ethnic Relations Commission, among others. He currently serves as a member of the Executive Board of the World Health Organization, Chair of the Guyana Global Fund Country Coordinating Mechanism, and the Caribbean representative on the UNAIDS Program Coordinating Board.

Sahar Bajis

Dr Paolo Balladelli

Director Subregional Program for South America OPS/OMS

Médico cirujano de nacionalidad Italiana, graduado en 1983 magna cum laude en la Universidad Alma Mater de Boloña, Italia con una tesis sobre el observatorio regional de salud. Recibió en 2002 el título de especialista en higiene y medicina preventiva, con una tesis en economía de la salud, ha realizado su recorrido internacional a lo largo de los últimos 38 años como: Coordinador residente de la ONU en Angola desde 2015 a 2020; Representante de la OPS y OMS en Venezuela (2020), Argentina (2011-2015), Guatemala (2009-2011), Colombia (2004-2009), Angola (2000-2004) y Croacia (1995-98); Director regional de la OMS para la crisis en Siria con base en Aman, Jordania (2013); Director de País en Ecuador (1984-1988), Bolivia (1989-1995) y Uganda (1998-1999) con la cooperación italiana-MRE Italia y Nombrado el 10 de agosto de 2021 como Director del Programa Subregional para América del Sur de la OPS OMS.

Po-Lin Chan

TEAM LEAD COMMUNICABLE DISEASES

Dr Po-Lin Chan is the Team Lead for Communicable Diseases at the World Health Organization India country office. She has worked in Africa, South Asia and East Asia in clinical services and conflict zones to advising government on public health initiatives. Passionately committed to Health for All, she led WHO’s technical assistance to India for their establishment of the foundation of the HIV/STI national public health response, scale-up and service decentralization two decades ago. She served as WHO Senior Advisor for Hepatitis, HIV and STI to support China in getting to elimination of viral hepatitis and during this time catalyzed the paradigm shift from dual to triple elimination of mother to child transmission of HIV, syphilis to include hepatitis B globally. She was previously the regional technical lead for viral hepatitis at the WHO regional office for the Western Pacific supporting 37 countries in getting to viral hepatitis elimination as a public health threat by 2030.

Chari Cohen

Dr Fuqiang Cui

Professor and Head of Department of Vaccine Research Center & Deputy Director of Department of Global Heath, School of Public Health, Peking University.

He used to be the technical officer of WHO headquarters, the Deputy Director of the National Immunization Programme, Chinese Center for Disease Control and Prevention, the Manager of Ministry of Health/Global Alliance on Vaccines and Immunization. Currently, Prof. Cui currently serves as the strategic information consultant for WHO HQ, the Expert Resource Panel of hepatitis B in WHO Western Pacific Region, the Chairman of Hepatitis Prevention and Control Branch of China Vaccine Industry Association, the vice president of the prevention and control of infectious disease control society, the Chinese Preventive Medicine Association (CPMA). He has published over 300 scientific articles. He is also the acting chief editor of Chinese Preventive Medicine, and the associate editor of Journal of Medical Virology.

Rosemary Delabre

Community-based Research Manager

Rosemary Delabre is the manager of the Community-based Research Laboratory at Coalition PLUS, an international Union of community-based organizations involved in the fight against HIV and viral hepatitis. She has a Masters in Public Health and a PhD in Epidemiology.

Meg Doherty

Philippa Easterbrook

Senior Scientist in the Global Hepatitis Programme, HIV department at the World Health Organisation Headquarters in Geneva.

Philippa Easterbrook is Senior Scientist in the Global Hepatitis Programme, HIV department at the World Health Organisation Headquarters in Geneva. She is an HIV and infectious diseases physician and epidemiologist who has worked in the UK, United States and Sub-Saharan Africa. At WHO, she has led the development and dissemination of global normative guidance for HIV as well as Hepatitis B and C testing and treatment. She also provides technical guidance to national programmes worldwide on the implementation of hepatitis B and C testing and treatment scale-up programmes as part of a global elimination strategy. For eleven years, she was Head of Department, Professor of HIV Medicine, and consultant physician in Infectious Diseases at King´s College London, and also Head of Research at the Infectious Diseases Institute in Uganda. Philippa has served as a Member of the UK Medical Research Council Infection and Immunity Committee, and was vice-chair of the World Health Organization Guidelines Review Committee. Her HIV research has encompassed epidemiology, clinical trials, operational and qualitative research, and laboratory-based studies.

Gupta Ekta

Dr. Ahmed Elsharkawy

Consultant Hepatologist

Ahmed Elsharkawy is a consultant hepatologist in Birmingham. He has a major interest in viral hepatitis and pioneered hepatitis C outreach clinics for marginalised populations in the city. He is past Chairman of the British Viral Hepatitis Group and current lead of the BASL specialist interest group in Hepatitis B. He is a strong advocate for the patient voice in viral hepatitis elimination and has been involved in trying to set up the first UK Hepatitis B patient group.

Dr Fatchanuraliyah

Ibrahima Gueye

Honour President Saafara Hépatites Senegal association

lbrahima Gueye is the founding president of the Saafara Hépatites Senegal association, which he created in 2011. He is also a member of the boards of directors of the African Liver Patients Association (ALPA) and the Alliance Afrique Francophone de Lutte contre les Hépatites. (AAFHe). He fights for the eradication of hepatitis in Senegal and around the world.

Aliya Hasnain

Margaret Hellard

Deputy Director at the Burnet Institute

Professor Margaret Hellard AM is a Deputy Director at the Burnet Institute, Head of Hepatitis Services in Department of Infectious Diseases at The Alfred Hospital.
Margaret’s research focuses on health equity; more specifically she is interested in reducing the impact and ending the epidemics of HIV/AIDS, hepatitis B, hepatitis C and COVID-19, particularly in socially and structurally disadvantaged groups.

Luciana Holtz

Founder and CEO “Founder and CEO of Oncoguia

Psychologist specialized in Psycho-oncology, Bioethics and Health Literacy”

Harry Janssen

Oanh Khuat

Executive Director of the Center for Support Community Development Initiatives (SCDI)

Oanh Khuat is a medical doctor graduated from Hanoi Medical University, with a Master Degree on Sexual and Reproductive Health Research from London School of Hygiene and Tropical Medicine. She is the co-founder and the Executive Director of the Center for Support Community Development Initiatives (SCDI) – a local non-governmental organization in Vietnam. Engaging with the most marginalized populations, her organization works towards an inclusive society in a sustainable planet using development approach.
In her other capacities, Oanh is the Chair of Council of Representatives of APCASO that focus on Asia-Pacific, and Chair of Global Fund Advocate Network, Asia and the Pacific.
In 2009, the World Economic Forum honored her as a Young Global Leader. In 2017, she was listed among the 50 Most Influential Vietnamese Women by Forbes Vietnam.

Justin Koonin

Niklas Luhmann

WHO

Dr Niklas Luhmann is a medical doctor with a Master of Science (Msc) in International Public Health from the University of Berlin. He has been working for more than 10 years with different institutions on access to healthcare with a focus around HIV and viral hepatitis related prevention, treatment and care. He joined WHO headquarters in Geneva in 2019 where he works as a technical officer and focuses on viral hepatitis prevention, testing and priority populations.

Rui Tato Marinho

Director National Priority Program for Viral Hepatitis

Head of Department of Gastroenterology and Hepatology, Hospital S. Maria
Full Professor of Medical School of Lisbon
Director of National Program for Viral Hepatitis, Ministry of Health
Member of General Council of University of Lisbon
Member of Interest Group in Hepatology of World Gastroenterology Organization
Operational Contact Point, ECDC (European Center for Diseases Control and Prevention)
Advisor of Governing Board of European Liver Patient Association (ELPA)
Director of Center of Palliative Medicine of Medical School of Lisbon
Medal of Merit of Portuguese Medical Association, 2015
President of Portuguese Society of Gastroenterology (2019-2021)
Advisory Member of Viral Hepatitis Prevention Board, since 2008
President of Portuguese Association for the Study of Liver (2007-2009)
Advisor of Governing Board of European Liver Patient Association (ELPA)
Meeting of Members of United European Gastroenterology (2014-2017, 2017-2021).
European Commission (Expert for the Programme H2020)
Fellow of American Association for the Study of Liver Diseases
World Gastroenterology Organisation: Hepatology Interest Group Member (2021)

Dorothy Mbori-Ngacha

SENIOR HIV SPECIALIST

Dr. Dorothy Mbori-Ngacha is the Senior HIV Specialist on EMTCT and Paediatric HIV for UNICEF’s global HIV/AIDS programmes. She is a medical doctor with specialist training in pediatrics, infectious disease and child health. She has extensive experience as a public health professional working in academia, the public sector, the NGO community, and international organizations. In her current role, she supports global efforts towards achievement of global targets to eliminate vertical transmission of HIV, syphilis, and Hepatitis B; and attain universal treatment coverage for women, children and adolescents living with HIV. A national of Kenya, Dr. Mbori-Ngacha holds a Medical Degree and a Master’s of Medicine in Paediatrics from the University of Nairobi School of Medicine, and a Master’s in Public Health (Epidemiology) from the University of Washington, Seattle.

Dr Hailemichael Desalegn Mekonnen

Associate Professor and Hepatologist and Vice President of Ethiopian Gastroenterology Association

Dr. Hailemichael Desalegn MD, PhD is a passionate advocate on Hepatitis Elimination from Ethiopia. He is currently working as an Associate Professor and Hepatologist and Vice President of Ethiopian Gastroenterology Association. He is a director of Sub-Saharan Africa Gastroenterology ECHO clinic. Dr. Hailemichael has many publications in reputable Journals. He has built one of the largest treatment cohorts for Hepatitis B in sub-Saharan Africa. He was also involved in simplified point of care tests for Hepatitis B and Hepatitis C viruses. He is currently a Post-doc at Vestfold Hospital, Norway for scale-up of Hepatitis B treatment in Ethiopia.

Luis Mendao

Eliana Monteforte

Global Health Council, Inc.

Eliana Monteforte is the Director of Special Projects at Global Health Council (GHC). In this role, she leads special projects and partnerships including grant-funded initiatives that engage civil society organizations, policymakers and global health networks to ensure minority voices are systematically heard and included in U.S. global health policy development and implementation. Prior to joining GHC, Eliana worked at Management Sciences for Health for over a decade where she provided project management and technical assistance support to various public health institutions and over 40 civil society organizations in Africa, Asia, Latin America and the Caribbean. Eliana’s areas of expertise include advocacy, health planning and budgeting, health finance, cost revenue analysis, and resource mobilization.

Antons Mozalevskis

WHO Technical Officer

Antons Mozalevskis is currently working as a Technical Officer, Key Populations, at the Global HIV, Hepatitis and STIs Programmes at WHO Headquarters. From 2015-2021 he was the serving as the regional focal point for viral hepatitis at WHO Regional Office for Europe.

Chris Munoz

Advisor

Past President of Yellow Warriors Society Philippines. 11yrs patient advocate. VP of Philippine Alliance of Patient Organizations.

Dr Morkor Newman

Medical Officer

A Medical officer, leading the work on elimination of mother to child transmission (EMTCT) of HIV, syphilis and hepatitis B virus, and women’s health in HIV within the Treatment and Care team of the Global HIV, Hepatitis and STI programs in WHO Geneva. She is also the acting Team Lead. She formerly worked in the Africa Regional Office and Ghana Country office for WHO and has extensive experience in communicable disease prevention and control, HIV and STI programming, particularly HIV prevention and EMTCT in high burden countries, as well as reproductive, maternal, neonatal and child health programs.

Alida Ngwije

Senior Program Manager-Infectious Diseases in Clinton Health Access Initiative (Rwanda)

Alida Ngwije is the Senior Program Manager for Infectious Diseases in Clinton Health Access Initiative (Rwanda). She holds a bachelor’s degree in Biotechnology and a master’s degree in International Public Health from the University of Sydney. Alida has been working in the health sector for over 10 years, both in public and private sectors. She is currently overseeing programs including COVID-19, Laboratory services, Sustainable access to Oxygen and the Hepatitis program. In the last 3 years, through CHAI’s support to the Government of Rwanda, Alida has been working closely with the Rwanda Biomedical Center (RBC) to design, implement and scale a Hepatitis program in Rwanda, with a major focus on advancing and achieving the country’s Hepatitis C elimination plan, launched in 2018.

Dr. Tasnia Noor

President (2021-22), Bangladesh Medical Students’ Society, National Member Organization of IFMSA

I’m currently practising as an intern doctor in a tertiary hospital in Dhaka, Bangladesh after completion of MBBS course of 6 years last year. I’ve spent the last 6 years as a young advocate for health in multiple roles in as a student and part of Bangladesh Medical Students’ Society, National Member Organization of IFMSA , which is one of the largest and oldest student run organization in the world, dedicated to health and rights. I started as a general member and last year was elected President of the term 2021-22 and practising the leadership role ever since , with many successes and learnings

John Tavis

Maia Tskhomelidze

Head of Department HIV/AIDS, Hepatitis, STI & TB National Center for Disease Control and Public Health

Dr. Maia Tsereteli graduated from the School of Public Health and Health Care Management at the Tbilisi State Medical University, where she continued to work reaching the position of Associate Professor. Dr. Tsereteli defended her Ph.D. in Public Health in 1997. Throughout these years she led the projects for various International organizations, such as CDC, AIHA, World Vision International, etc. Since 2011 she is the Head of Division of HIV/AIDS, Hepatitis, TB and STIs at the National Center for Disease Control and Public Health of Georgia, responsible for the surveillance of the a.m. diseases in the country. As a National Expert Dr. Tsereteli is involved in the strategy development, programme planning and epidemiology studies. She is a member of State Scientific Committee on HCV elimination and State Commission on HCV Elimination Program.

Currently, in close collaboration with CDC US and WHO, Dr. Tsereteli actively contributes to the development and implementation of the Viral Hepatitis Elimination country strategy.

Homie Razavi

Dr. B. Rewari

Lewis Roberts

Professor of Medicine

Dr. Lewis R. Roberts is the Peter and Frances Georgeson Professor in Gastroenterology Cancer Research and consultant in Gastroenterology and Hepatology at the Mayo Clinic, where he is Co-Principal Investigator of the Mayo Specialized Program of Research Excellence (SPORE) in Hepatobiliary Cancers. His research focuses on molecular mechanisms of liver and biliary carcinogenesis; biomarkers for diagnosis of liver, bile duct and pancreas cancers; and prevention, diagnosis and treatment of hepatitis and liver cancer, with a particular interest in immigrant African communities in the USA as well as in Africa. He has authored over 400 articles, book chapters and letters, and co-edited the book “Evaluation and Management of Liver Masses”. He serves as President of Africa Partners Medical, a non-profit organization focused on improving healthcare delivery in Africa through medical education, practical skills training, provision of medical equipment and supplies, and health advocacy; as President of the West Africa Institute for Liver and Digestive Diseases Foundation; and as a member of the Advisory Council for The Hepatitis Fund. Dr. Roberts is also a founding member of the Africa HepatoPancreatoBiliary Cancer Consortium.

Finn Jarle Rode

Executive Director at the Hepatitis Fund

Finn Jarle Rode is Executive Director at the Hepatitis Fund. Previously he was Executive Director at the Oslo Center, where he ran a turnaround operation, both in terms of finances as well as strategically. Finn Jarle has previously served as Director in the Global Partnership team of the International Federation of Red Cross and Red Crescent Societies (IFRC) headquarters in Geneva. He has more than 20+years of experience in IFRC/ICRC and Norwegian Red Cross. He has been IFRC’s Country Director in Afghanistan, North Korea, Regional Director for Eastern Africa, and Indian Ocean Islands. Finn Jarle also held different positions in the private sector in Norway, including within shipping and the hotel industry. He holds an MBA from Heriot-Watts with in depth focus on organisational development and international finance.

Sigrun Roesel

Andrew Scheibe

Technical Advisor

Dr Andrew Scheibe is a medical doctor by training who works in harm reduction research, programmes and policy in South Africa and the region. His work focuses on the intersections between infectious diseases, determinants of health, drugs and rights. He works as an independent consultant and is also a technical advisor for TB HIV Care and is a researcher at the University of Pretoria’s Department of Family Medicine and a visiting professor at the Urban Futures Centre at the Durban University of Technology

Gamal Shiha

CEO & Founder – Egyptian Liver Research Institute and Hospital

Gamal Shiha, MD, is a graduate of Faculty of medicine, Mansoura University with honor. He trained in internal medicine at the Mansoura University Hospital (MUH) and Faculty of Medicine, Mansoura, Egypt. Shiha has been practicing since 1982, He is the Founder and Head of the Association of Liver Patients’ Care (ALPC), Dakahlia, Egypt since 1997. Also, Founder and CEO of the Egyptian Liver Research Institute and Hospital since 2011. Shiha is also a Prof. Internal Medicine. Department Gastroenterology and liver unit; Faculty of Medicine, Mansoura University.

Prof Jing Sun

Jing Sun is an associate professor of pharmaceutical policy at the School of Health Policy and Management, Chinese Academy of Medical Science and Peking Union Medical College. She is also the leader of the Pharmaceutical Policy Theme Group-China Core Group of the International Network of Rational Use of Drug (INRUD) and the country leader of the BRICS Medicines Alliance. Her extensive work experiences in national vaccine institute, regulatory authority, international health organization, research and academic institutes render her knowledge and skills in pharmaceutical science, project management and policy research. Her research areas focus on pharmaceutical policy analysis and specialized in pharmaco-economics and pharmaco-epidemiology. Since 2004, she has been involved in providing technical support to the Chinese government in the pharmaceutical area, and contributed to China’s national health system reform, especially the reforms in the pharmaceutical sector. Jing Sun received her PhD from the Graduate School of Medical Sciences at the University of Groningen of the Netherlands. She received her MSc. of International Health Policy from London School of Economics of UK and her Bachelor of Pharmaceutical Chemistry from the Peking Medical University of China. Jing Sun was a Chevening Scholar of LSE Health, and was granted a Chevening fellow for the Oxford Healthcare, Health Policy and Health Reform program.”

Julia Tainijoki – Seyer

Senior Medical and Advocacy Advisor, World Medical Association

Dr Tainijoki-Seyer is the Senior Medical and Advocacy Advisor of the World Medical Association, the global federation of National Medical Associations representing the millions of physicians worldwide. WMA acts on behalf of patients and physicians to achieve the highest possible standards of medical care, ethics, education and health-related human rights for all people. Dr Tainijoki manages a variety of strategic projects at WMA ranging from infectious and non-communicable diseases to strengthening health systems, patient safety, access to quality-assured medicines and the social determinants of health. She serves as the WMA representative to the UN organizations, including WHO and other international institutions in Geneva, Switzerland. For over 10 years she also headed the secretariat of the World Health Professions Alliance (WHPA) representing more than 26 million healthcare professionals globally, is advisory board member of the Civil Society Engagement Mechanism for UHC2030, Members of the Steering Group on Influenza Vaccination, was member of several international expert committee at WHO and other organisations, management board member of the Global Social Observatory and editorial board member of Southern Medical Journal. She is a family physician, trained in Germany, UK and Switzerland with a Master’s Degree in International Health Economy, Public Health and Health Policy from the University of Bocconi in Milan, Italy.

Lien Tran

Researcher, WHO Collaborating Centre for Viral Hepatitis, Doherty Institute

Lien is an epidemiologist and PhD scholar at the WHO Collaborating Centre for Viral Hepatitis, Doherty Institute, Melbourne, Australia. Her research focuses on hepatitis B care delivery in primary care. She is an active advocate for people and communities affected by hepatitis at national and international level. Lien currently serves as Regional Board Member for the World Hepatitis Alliance, representing the WHO Western Pacific Region.

Prof Carla Treloar

Director – Centre for Social Research in Health and the Social Policy Research Centre at UNSW

Professor Carla Treloar is a social scientist in public health and health services research. She is Professor and Director of the Centre for Social Research in Health and the Social Policy Research Centre at UNSW Sydney, Australia.

David Urick

Direct care support coordinator

David Urick is a 33 year old chronic Hepatitis B patient and advocate. He lives in Ypsilanti, Michigan and works as a direct patient care supervisor. His advocacy work has emboldened him to be part of the solution to prevent/cure Hep B, raise awareness, and inspire other patients to advocate for their health.

Dr Patricia Vélez Möller

Vice President – Guatemalan Liver Association

Physician with Master degree in Public Health (MPH) and postgraduate studies in microbiology. Professor at Medical School of San Carlos University of Guatemala for 35 years.
Co-Founder and Board Member of the Guatemalan Liver Association, member of Guatemala National Task Force on Hepatitis, Board Member of World Hepatitis Alliance.
Participation in hepatitis elimination efforts through different activities including the development of Guatemala Ministry of Health Hepatitis B & C Guidelines, in coordinating hepatitis vaccination and testing campaigns and continued education to healthcare workers. Advisor on viral hepatitis elimination to different national and international entities. Dr Patricia Vélez Möller Vice President “Physician with Master degree in Public Health (MPH) and postgraduate studies in microbiology. Professor at Medical School of San Carlos University of Guatemala for 35 years. Co-Founder and Board Member of the Guatemalan Liver Association, member of Guatemala National Task Force on Hepatitis, Board Member of World Hepatitis Alliance.
Participation in hepatitis elimination efforts through different activities including the development of Guatemala Ministry of Health Hepatitis B & C Guidelines, in coordinating hepatitis vaccination and testing campaigns and continued education to healthcare workers. Advisor on viral hepatitis elimination to different national and international entities.

John Ward

Director of the Coalition for Global Hepatitis Elimination

Director of the Coalition for Global Hepatitis Elimination

Han Yang

Dr Marie Emmanuelle Zoure